Genix Pharmaceuticals Corporation
GENX.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.50K | -60.80K | -36.60K | -75.50K | 112.80K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -600.00 |
| Total Amortization of Deferred Charges | 200.00 | 200.00 | 200.00 | 200.00 | 800.00 |
| Total Other Non-Cash Items | 41.50K | 30.80K | 20.90K | 33.60K | -165.70K |
| Change in Net Operating Assets | 2.40K | 18.40K | 5.50K | -2.80K | 23.20K |
| Cash from Operations | -22.40K | -11.40K | -10.00K | -44.40K | -29.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.10K | 16.00K | 15.40K | 54.80K | 41.60K |
| Total Debt Repaid | -30.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 100.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.10K | -- | -- | -- | -- |
| Cash from Financing | 50.40K | 11.70K | 10.80K | 38.60K | 30.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.10K | 200.00 | 800.00 | -5.80K | 900.00 |